Banco Bilbao Vizcaya Argentaria, S.A. Bio Xcel Therapeutics, Inc. Transaction History

Banco Bilbao Vizcaya Argentaria, S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$37.44 - $64.63 $799,718 - $1.38 Million	-21,360 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$12.26 - $41.14 $351,126 - $1.18 Million	-28,640 Reduced 57.28%	21,360 $477,000
Q4 2019 Feb 13, 2020	BUY	$4.05 - $14.61 $202,500 - $730,500	50,000 New	50,000 $730,000

3.13M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $9.53M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Banco Bilbao Vizcaya Argentaria, S.A., based on Form 13F filings with the SEC.

Stay updated on Banco Bilbao Vizcaya Argentaria, S.A. with notifications on news.